The most significant changes were observed for FGF-2 and IP-10 in both IM-naive and -resistant GIST cells (Figure 1A,B, respectively), whereas the increase of IL-6 and GRO was specific for IM-resistant GISTs treated with IM. Here, CXCL1 is linked to gastrointestinal stromal tumor.